Skip to content
value.today

10x Genomics, Inc. vs Simulations Plus, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • 10x Genomics, Inc. is the larger company by market value: $9.4 B against $371 M for Simulations Plus, Inc., 25 times as much (market caps of Oct 26, 2026 for 10x Genomics, Inc. and Aug 1, 2026 for Simulations Plus, Inc.). Simulations Plus, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
  • 10x Genomics, Inc. had more revenue: $643 M in the year to December 2025 against $79 M for Simulations Plus, Inc. in the year to August 2025.
  • Both made a net loss: $44 M for 10x Genomics, Inc. and $65 M for Simulations Plus, Inc.
  • 10x Genomics, Inc. keeps more of each dollar of sales: a net margin of -6.8% against -81.7% for Simulations Plus, Inc.
  • Simulations Plus, Inc.'s revenue grew faster in its latest fiscal year: +13.1% against +5.2% for 10x Genomics, Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

072143215287202020212022202320242025202610x Genomics, Inc. 135Simulations Plus, Inc. 74

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$1B20172018201920202021202220232024202510x Genomics, Inc. $1BSimulations Plus, Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
Measure10x Genomics, Inc.
TXG · #2,271 in the world
Simulations Plus, Inc.
SLP
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryHealthcare Information ServicesHealthcare Information Services
Founded20121996
Size
Market cap$9.4 B$371 M*
Revenue$643 M$79 M
Net income$-44 M▲ best$-65 M
Employees1,243—
Valuation
Price to sales15.2×—
Price to book11.8×—
Free cash flow yield1.4%—
Profitability
Gross margin69.0%▲ best58.4%
Operating margin-9.5%▲ best-89.3%
Net margin-6.8%▲ best-81.7%
Return on equity-5.8%▲ best-42.1%
Growth
Revenue growth5.3%13.1%▲ best
Revenue growth, 3 years a year7.6%13.7%▲ best
Cash
Free cash flow margin20.2%22.0%▲ best
Altman Z-score zonesafe—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Aug 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, 10x Genomics, Inc. or Simulations Plus, Inc.?

10x Genomics, Inc. is the larger company by market value: $9.4 B against $371 M for Simulations Plus, Inc., 25 times as much (market caps of Oct 26, 2026 for 10x Genomics, Inc. and Aug 1, 2026 for Simulations Plus, Inc.). Simulations Plus, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.

Which makes more money, 10x Genomics, Inc. or Simulations Plus, Inc.?

10x Genomics, Inc. had more revenue: $643 M in the year to December 2025 against $79 M for Simulations Plus, Inc. in the year to August 2025. Both made a net loss: $44 M for 10x Genomics, Inc. and $65 M for Simulations Plus, Inc.

Which is more profitable, 10x Genomics, Inc. or Simulations Plus, Inc.?

10x Genomics, Inc. keeps more of each dollar of sales: a net margin of -6.8% against -81.7% for Simulations Plus, Inc.

Which is growing faster, 10x Genomics, Inc. or Simulations Plus, Inc.?

Simulations Plus, Inc.'s revenue grew faster in its latest fiscal year: +13.1% against +5.2% for 10x Genomics, Inc.

Sources#

Every figure on this page comes from these, with the date shown next to it.